Stay updated on Selpercatinib in RET-Mutant Medullary Thyroid Cancer Clinical Trial

Sign up to get notified when there's something new on the Selpercatinib in RET-Mutant Medullary Thyroid Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Selpercatinib in RET-Mutant Medullary Thyroid Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page has been updated to include new information about Medullary Thyroid Cancer and its associated study, while significant details regarding the study's purpose and eligibility criteria have been removed.
    Difference
    12%
    Check dated 2025-04-16T14:29:23.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to February 27, 2025.
    Difference
    0.2%
    Check dated 2025-04-09T09:17:06.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new version release, moving from v2.14.2 to v2.14.3, and the last update date has changed from February 27, 2025, to March 25, 2025.
    Difference
    0.2%
    Check dated 2025-04-01T23:19:43.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    49 days ago
    Change Detected
    Summary
    The webpage has updated its date references to include new dates in February 2025, while older dates have been removed.
    Difference
    1.0%
    Check dated 2025-03-03T23:56:35.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    The webpage has updated its timelines for disease progression metrics, extending some durations from 35 months to 39 months, and has removed several outdated dates and metrics. Additionally, there is a notice regarding heavy traffic affecting service performance.
    Difference
    2%
    Check dated 2025-02-10T17:49:40.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    The website has been updated from version v2.14.1 to v2.14.2.
    Difference
    0.0%
    Check dated 2025-02-03T12:57:27.000Z thumbnail image

Stay in the know with updates to Selpercatinib in RET-Mutant Medullary Thyroid Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Selpercatinib in RET-Mutant Medullary Thyroid Cancer Clinical Trial page.